Monell Chemical Senses Center

What Monell Chemical Senses Center does

The Monell Chemical Senses Center is an independent nonprofit scientific institute founded in 1968 and headquartered in Philadelphia, Pennsylvania. It is the world's only institute singularly dedicated to the scientific understanding of taste and smell (chemosensory science), operating from laboratories at the University City Science Center with a planned relocation to One uCity Square in 2026. Monell conducts multidisciplinary research spanning molecular biology, neuroscience, behavioral science, and clinical investigation, organized around three core research themes — Healthy Senses and Happy Lives, Senses for a Thriving Planet, and Nourishing Our Future.

Monell's deliverables are research outputs rather than commercial products: peer-reviewed publications, clinical research services, and licensed technologies. Notable proprietary capabilities include the SCENTinel rapid smell test (licensed to a startup company for COVID-19 and general smell loss diagnostics), cultured human taste cell technology for bitter-taste blocker screening, olfactory stem cell organoid platforms, and Mendelian randomization methods linking taste/smell genetics to chronic disease. The center has contributed landmark findings including genetic factors behind garlic-flavor transmission to human milk (2025 Ig Nobel Prize), oleocanthal's effect on Alzheimer's-related proteins, and quantification of COVID-19 smell loss (affecting up to 80% of infected individuals). Its Smell for Life program advances anosmia research, while the Chemosensory Clinical Research partnership with Thomas Jefferson University Hospital translates findings into clinical treatments including platelet-rich plasma therapy (50% clinical improvement in Phase I).

Monell's economic model is a grant-funded nonprofit: philanthropic grants (led by the Ambrose Monell Foundation's $26M five-year commitment) and federal research grants (NIH, RADx, NIDCD, NIA, PCORI) form the core funding base, supplemented by corporate partnerships through the Monell Insiders program, technology licensing royalties, and individual donations. The organization serves three primary constituencies: academic and research institutions (via the Monell Academic Partnership Program), corporate partners in food, beverage, fragrance, pharmaceutical, and chemical industries, and healthcare providers and patients with chemosensory disorders. Patient advocacy organizations (AbScent, FifthSense, STANA) and the public are engaged through educational programming including the Sense Making podcast, World Taste & Smell Day, and the Dr. Charis Eng Monell Science Apprenticeship Program for high school and undergraduate trainees.

Name

Monell Chemical Senses Center

Legal name

Monell Chemical Senses Center

Website

https://monell.org

Company type

Private

Founded year

1968

Operating status

Operating

Headcount range

101–250 employees

Short description

Monell Chemical Senses Center is an independent nonprofit research institute in Philadelphia, founded in 1968, that conducts multidisciplinary chemosensory (taste and smell) science funded primarily through grants from the Ambrose Monell Foundation, NIH, and corporate partners in food, fragrance, and pharmaceutical industries.

Ownership category

akta.pro rank

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Philanthropic Grants: Major grant funding from foundations such as the Ambrose Monell Foundation ($26 million over five years) to support research in chemosensory science, health improvements, disease detection, and sensory technology development.
2. Government Research Funding: Funding from National Institutes of Health (NIH) and other government agencies for specific research projects including SCENTinel development, COVID-19 research, and ongoing scientific studies.
3. Corporate Partnerships: Collaborations with food, beverage, fragrance, pharmaceutical, and chemical industries through the Monell Insiders corporate partner program. Includes funded research partnerships with companies like Discovery BioMed Inc.
4. Donations: Individual donor contributions and support, including named memorial donations and research support funds like the George Preti Research Support Core for Analytical Chemistry.
5. Technology Transfer and Licensing: Licensing of developed technologies such as SCENTinel to startup companies for commercial application.

Distribution channels4 records

Marketing channels11 records

Core offering

The Monell Chemical Senses Center is a nonprofit independent scientific institute conducting fundamental and translational research on the chemical senses of taste and smell. It delivers research services, develops proprietary diagnostic and cellular technologies (such as the SCENTinel rapid smell test, cultured human taste cells, and olfactory stem cell models), provides postdoctoral and apprenticeship training, and licenses selected technologies for commercial development. Research findings are disseminated through peer-reviewed publications, clinical partnerships, patient advocacy collaborations, and public education resources.

Product overview

The Monell Chemical Senses Center is an independent nonprofit research institute dedicated to the scientific understanding of taste and smell. Rather than offering a commercial product platform, Monell conducts fundamental chemosensory research and provides research participation opportunities. The organization operates several research programs including the Smell for Life Program focused on anosmia causes and treatments, developed the SCENTinel rapid smell test for clinical diagnostics, offers educational content through the Sense Making podcast, and provides training programs including the Dr. Charis Eng Monell Science Apprenticeship Program. Research participation opportunities allow individuals to contribute to studies on taste, smell, and sensory perception.

Differentiator

Problem solved

Functional benefit

Brands

• Smell for Life: A campaign and research portfolio dedicated to understanding the mechanisms of the sense of smell, treating smell disorders, and advancing olfactory science.
• SCENTinel
• Dr. Charis Eng Monell Science Apprenticeship Program

Products and services

• SCENTinel Rapid Smell Test A rapid smell test developed by Monell-Temple scientists Dr. Pamela Dalton and Dr. Valentina Parma, designed for clinical situations to identify individuals with smell loss, including COVID-19 symptom screening. The test is administered quickly without trained personnel, uses easily identified odors, has multiple versions for repeat testing, presents odor choices at consistent intensity, is offered as single-use material, and is designed so correct answers are not easy to guess.
• Chemosensory Clinical Research Clinical research services assessing taste and smell function of patients, conducted through partnerships with healthcare institutions including Thomas Jefferson University Hospital. Includes clinical trials such as platelet-rich plasma (PRP) treatment for olfactory disturbance and TMAU biochemical testing through Children's Hospital Colorado.
• Dr. Charis Eng Monell Science Apprenticeship Program A signature summer research program offering immersive, paid research experiences where high school and undergraduate apprentices work alongside Monell scientists while exploring careers in biomedical science, medicine, and health research. Formerly known as MSAP, the newly renamed program continues the same summer research experience.

Quantifiable outcome

• Genetic variant linked to onion preference associated with ~1.3 mmHg lower systolic blood pressure and ~0.7 mmHg lower diastolic blood pressure per point on liking scale, plus ~14% reduced risk of type 2 diabetes
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

15 partnerships are on record, tiered core and major.

• University of QueenslandcoreStrategic or Co-development PartnerAcademic research partner collaborating on genetic framework study using taste and smell genes to understand how diet contributes to chronic disease, testing 325 genes against food preferences and intake data.
• University of BristolcoreStrategic or Co-development PartnerAcademic partner providing UK Biobank data validation through the children of the 90s study from Bristol, UK to confirm genetic research findings in a younger population.
• QIMR Berghofer Medical Research InstitutecoreStrategic or Co-development PartnerResearch institute collaborating on international team studying genetic variants in taste and smell receptor genes and their impact on food preferences and health outcomes.
• Thomas Jefferson University HospitalcoreStrategic or Co-development PartnerClinical research partner conducting platelet-rich plasma (PRP) clinical trial for smell loss treatment, led by otolaryngologist Dr. David Rosen. Phase I showed 50% clinically significant improvements. Also partner in Chemosensory Clinical Research Center.
• Global Consortium for Chemosensory Researchers (GCCR)coreStrategic or Co-development PartnerInternational research consortium formed in 2020 in response to COVID-19 smell and taste loss, conducting crowd-sourced data collection and standardized surveys on chemosensory symptoms across multiple languages and countries.
• Discovery BioMed Inc.coreStrategic or Co-development PartnerHuman cell-based drug discovery contract research organization partnering with Monell on $271,000 NIH STTR grant for bitter taste blocker development using high-throughput screening assays on taste cells supplied by Monell.
• Macgillivray Freeman FilmsmajorStrategic or Co-development PartnerFilm production company collaborating on IMAX feature film 'Super Human Body: World of Medical Marvels' with educational content about sensory science, supported by Ambrose Monell Foundation.
• AbScentmajorStrategic or Co-development PartnerUK-registered charity founded by Chrissi Kelly for helping address distressing effects of smell loss. Funded research including Dr. Stephanie Hunter's food enjoyment study. Monell scientists participate in their educational events.
• Fifth SensemajorStrategic or Co-development PartnerFirst UK charity established to provide education, information, support, and guidance to people and their families affected by smell and taste disorders. Duncan Boak spoke at Monell in 2017.
• Smell and Taste Association of North America (STANA)coreStrategic or Co-development PartnerFirst 501c3 organization serving North American patients with taste and smell disorders, established with Monell advising. Partnering with others worldwide for awareness and advocacy. Launched 2023 petition for universal smell testing.
• World Taste and Smell DaymajorStrategic or Co-development PartnerNon-profit organization established by Monell Center in 2021 to create first-ever World Taste & Smell Day, featuring online world exploratorium and fundraising for patient advocacy efforts.
• University of PennsylvaniacoreStrategic or Co-development PartnerAcademic partner institution where Monell originated in 1968. Ongoing collaborations including neuroscience research, faculty appointments, and academic partnership program.
• Temple UniversitycoreStrategic or Co-development PartnerAcademic partner collaborating on COVID-19 smell research including kids outreach activities for children to monitor taste and smell changes, and joint development of SCENTinel rapid smell test.
• Children's Hospital ColoradocoreStrategic or Co-development PartnerClinical partner handling all TMAU testing through their Biochemical Genetics Laboratory, testing for trimethylaminuria using biochemical laboratory test measuring trimethylamine in urine after choline challenge.
• Monell Academic Partnership ProgramcoreStrategic or Co-development PartnerNetwork of academic collaborators bringing added strength and expertise to the Center's research mission, including international institutions like University of Queensland, University of Bristol, and QIMR Berghofer.

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Allen Institute: Independent, nonprofit scientific research institute conducting large-scale brain and neural science research, including olfactory neural circuits. Highly comparable operating model to Monell as a focused, grant-funded research nonprofit (not affiliated with a university) producing both fundamental science and licensable tools.
• Salk Institute for Biological Studies: Independent nonprofit biological research institute in La Jolla, California. Comparable in operating structure to Monell as a freestanding research organization reliant on grants/donations, with translational research output.
• Wyss Institute for Biologically Inspired Engineering: Independent research institute focused on biologically inspired engineering and biotech R&D with technology translation to industry. Comparable to Monell in translating lab research into commercial applications through licensing and partnerships.
• Rockefeller University: Independent biomedical research university with significant chemosensory and neuroscience research, including Heilbrunn Nurse Scholar Award funding referenced as a Monell partner. Comparable operating model of focused biomedical research with grant funding.
• Whitehead Institute for Biomedical Research: Independent nonprofit research institute affiliated with MIT focused on biomedical research. Comparable in operating structure as a freestanding research institute with similar funding mix and translational ambitions.

Broad incumbents

• Howard Hughes Medical Institute (HHMI): Large nonprofit biomedical research organization funding investigator-driven science. Comparable as a major funder/operator of basic biomedical research, though much broader in scope than Monell's chemosensory focus.
• Givaudan: World's largest flavor and fragrance company with significant in-house sensory science and chemosensory research. Comparable as a corporate actor in chemosensory R&D and a likely Monell Insiders partner, though driven by commercial product development.
• International Flavors & Fragrances (IFF): Major flavor, fragrance, and sensory science company with substantial R&D programs in taste and smell. Comparable industry overlap as a corporate sensory-science R&D player potentially partnering with or competing for the same talent pool as Monell.
• Symrise: Global flavor and fragrance manufacturer with a dedicated taste, nutrition, and health R&D division. Comparable in working at the intersection of chemosensory science and consumer product development.
• Firmenich: Leading flavor and fragrance company with deep investment in taste and olfaction research. Comparable corporate sensory-science research capability and overlapping corporate partner pool with Monell.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@monellcenter
• LinkedInlinkedin.com/company/monell-chemical-senses-center
• Xx.com/monellsc
• Facebookfacebook.com/117956561614817

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monell Chemical Senses Center